课题基金 / 基金详情

Pharmacological chaperones for F508del-CFTR and their mechanisms of action.

Pharmacological chaperones for F508del-CFTR and their mechanisms of action.
F508del-CFTR 的药理学伴侣及其作用机制。
批准号:
366639
负责人:
Hanrahan John W
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-11-01 至 2017-11-01

项目摘要

项目成果

Hanrahan John W的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质在许多疾病中起着至关重要的作用。错误折叠的蛋白质经常被错误定位和降解,但如果它们到达正常的细胞位置,它们仍然可以发挥功能。在蛋白运输性疾病、囊性纤维化中,突变蛋白F508delCF
英文摘要
Proteins play vital roles in many diseases. Misfolded proteins are often mislocalized and degraded, but they can still function if they reach their normal cellular location. In the protein trafficking disease, cystic fibrosis, the mutant protein F508delCF
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Smoke effects on cell function and role in COPD
  • 批准号:
    498305
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2023
  • 负责人:
    Hanrahan John W
  • 依托单位:
Pharmacological chaperones that bind F508del-CFTR and their mechanisms of action
  • 批准号:
    370768
  • 项目类别:
    Operating Grants
  • 资助金额:
    $67.6万
  • 财政年份:
    2017
  • 负责人:
    Hanrahan John W
  • 依托单位:
Induced pluripotent stem cells for identification of novel drug combinations targeting cystic fibrosis lung and liver disease
  • 批准号:
    332061
  • 项目类别:
    Operating Grants
  • 资助金额:
    $16.03万
  • 财政年份:
    2015
  • 负责人:
    Hanrahan John W
  • 依托单位:
CFTR modulators as a potential new therapeutic paradigm to treat individuals with COPD
  • 批准号:
    308201
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.63万
  • 财政年份:
    2014
  • 负责人:
    Hanrahan John W
  • 依托单位:
海外基金